SAN ANTONIO, Texas - A federal judge has issued an order in favor of Healthpoint, Ltd., in a civil suit involving the infection prevention company and Ethex Corporation.
The marketing of Ethex products was the cause of litigation.
Reportedly, judge said "Ethex made a deliberate choice to make representations about its products that were false, knowing that such representations would cause substantial injury to Healthpoint."
Healthpoint officials initially alleged Ethex officials of marketing their product Ethexyme as a generic and alternative option in lieu of Healthpoint's prescription ointment Accuzyme. They also alleged Ethex officials marketed the two products had the same ingredients, when in fact they did not.
On this matter, the judge said, "Ethex's statement that Ethexyme had the `same ingredients in the same quantities' as Accuzyme was literally false."
H. Paul Dorman, chairman and CEO of Healthpoint, says such terms are devious.
"Such false statements led hospitals, pharmacies and other institutions to substitute Ethexyme for Accuzyme," he says. "The jury and judge have reinforced emphatically that patients should not be subjected to the inherent dangers associated with improper substitution."
For more information, visit: www.healthpoint.com.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Breaking the Cycle of Silence: Why Sharps Injuries Go Unreported and What Can Be Done
Published: July 24th 2025 | Updated: July 23rd 2025Despite decades of progress in health care safety, a quiet but dangerous culture still lingers: many health care workers remain afraid to report sharps injuries, fearing blame more than the wound itself.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.